BMY has shed units like rare disease and PFE just shedded units. Who knows, but will be an intersting call on the 30th..
Chris Schott
Yeah. Hopefully, this time around, you'll be there. There's been a lot of talk about potential consolidation across the pharma group, including large M&A.
You run a very large R&D organization. It's been through consolidation over time. To the extent there is activity and Pfizer is involved, how do you think about maintaining the momentum that you currently have in the organization, again, if a deal were to happen.
And we've seen in the past, when you get large consolidation, there can be disruption. Are there learnings you have in place? Or your comfort that if a deal were to happen, you can kind of keep this going, how do you think about managing that challenge?
Mikael Dolsten
For large companies, it's important always to look at opportunity to augment, accelerate growth. And whether that's smaller or midsize bolt-on or assessing larger opportunities in order to maximize shareholder value and return, so that's, obviously, a capability that we have and do it regularly, routinely.
When it comes to the specific questions, and let me simplify from the Wyeth decision, where I think the recipe for success is the experience that our organization has in moving swiftly and engaging in that case with another company, looking at best practice across the two companies, rolling out the roadmap how you combine, in this case, the R&D, the strength in each therapeutic areas, the technical design of drugs, and quickly create one single pipeline go forward.
We did all of that work with Wyeth-Pfizer acquisition basically in less than a month. And then took firm, but important and difficult decision, on where to focus, which therapeutic areas, which sides and how to allocate our resources.
And I think that culture, that capability is very strong at Pfizer, possibly uniquely strong in the industry.
And, of course, we saw that also, at a smaller scale, I spoke today about the PROSPER trial, the positive readout and our on-track plans to file first half of the year with Astellas, we accelerated after the acquisition of Medivation that started with two years.
And then, finally, the Anacor acquisition and the drug Eucrisa, we were able at just registration phase to resolve a number of issues, given our capability in CMC and pharmaceutical sciences that allowed a very fast registration to occur.
So, I think independence and scale, that's a key capability that our company has. And, of course, it's important to look at such opportunities in a very unbiased manner as part of your running a business.
Recent PFE News
- Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets • Business Wire • 09/25/2024 09:00:00 PM
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union • Business Wire • 09/20/2024 12:11:00 PM
- Targeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer Hope • AllPennyStocks.com • 09/17/2024 09:01:00 PM
- Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts • Business Wire • 09/17/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 05:12:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 05:11:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 05:06:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 05:04:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:57:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:56:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:54:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:53:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:47:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:45:23 PM
- Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia • Business Wire • 09/14/2024 12:45:00 PM
- Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer • Business Wire • 09/14/2024 08:15:00 AM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 09/13/2024 08:49:43 PM
- Pfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024 • Business Wire • 09/11/2024 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 10:10:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 10:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 10:05:28 PM
- Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference • Business Wire • 08/28/2024 02:00:00 PM
- Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare • Business Wire • 08/27/2024 10:45:00 AM
- Cruise and Uber Join Forces for Robotaxis, Alibaba Shifts Primary Listing to Hong Kong, Altria Hikes Dividend 4.1% • IH Market News • 08/23/2024 12:20:26 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM